JP2017506214A5 - - Google Patents

Download PDF

Info

Publication number
JP2017506214A5
JP2017506214A5 JP2016544451A JP2016544451A JP2017506214A5 JP 2017506214 A5 JP2017506214 A5 JP 2017506214A5 JP 2016544451 A JP2016544451 A JP 2016544451A JP 2016544451 A JP2016544451 A JP 2016544451A JP 2017506214 A5 JP2017506214 A5 JP 2017506214A5
Authority
JP
Japan
Prior art keywords
antigen
binding portion
isolated antibody
antibody
tumor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2016544451A
Other languages
English (en)
Japanese (ja)
Other versions
JP2017506214A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/IL2015/050009 external-priority patent/WO2015101998A1/en
Publication of JP2017506214A publication Critical patent/JP2017506214A/ja
Publication of JP2017506214A5 publication Critical patent/JP2017506214A5/ja
Pending legal-status Critical Current

Links

JP2016544451A 2014-01-02 2015-01-01 癌を治療するためのFrizzled受容体抗体 Pending JP2017506214A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201461922893P 2014-01-02 2014-01-02
US61/922,893 2014-01-02
PCT/IL2015/050009 WO2015101998A1 (en) 2014-01-02 2015-01-01 Frizzled receptor antibodies for treatment of cancer

Publications (2)

Publication Number Publication Date
JP2017506214A JP2017506214A (ja) 2017-03-02
JP2017506214A5 true JP2017506214A5 (cg-RX-API-DMAC7.html) 2018-01-25

Family

ID=53493369

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2016544451A Pending JP2017506214A (ja) 2014-01-02 2015-01-01 癌を治療するためのFrizzled受容体抗体

Country Status (6)

Country Link
US (1) US10465004B2 (cg-RX-API-DMAC7.html)
EP (1) EP3089995A4 (cg-RX-API-DMAC7.html)
JP (1) JP2017506214A (cg-RX-API-DMAC7.html)
CA (1) CA2935630A1 (cg-RX-API-DMAC7.html)
IL (1) IL246540A0 (cg-RX-API-DMAC7.html)
WO (1) WO2015101998A1 (cg-RX-API-DMAC7.html)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3089995A4 (en) 2014-01-02 2017-11-29 Tel HaShomer Medical Research Infrastructure and Services Ltd. Frizzled receptor antibodies for treatment of cancer
WO2017100154A1 (en) * 2015-12-07 2017-06-15 Purdue Research Foundation Inhibitors for proliferating cell nuclear antigen and uses
CN112159474B (zh) * 2019-11-06 2021-11-19 上海健康医学院 一种靶向Frizzled7人源化抗体及其制备方法与应用
WO2026051924A1 (zh) * 2024-09-03 2026-03-12 浙江道尔生物科技有限公司 抗fzd7单域抗体及其应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7867705B2 (en) * 2004-09-21 2011-01-11 Rhode Island Hospital, A Lifespan-Partner Frizzled proteins and detection and treatment of cancer
EP2500360B1 (en) * 2005-10-31 2015-08-05 Oncomed Pharmaceuticals, Inc. Compositions and methods for diagnosing and treating cancer
EP2331136B1 (en) * 2008-09-26 2018-01-10 OncoMed Pharmaceuticals, Inc. Frizzled-binding agents and uses thereof
WO2011004379A1 (en) * 2009-07-10 2011-01-13 Tel Hashomer Medical Research Infrastructure And Services Ltd. Compositions and methods for treating cancer
EP3089995A4 (en) 2014-01-02 2017-11-29 Tel HaShomer Medical Research Infrastructure and Services Ltd. Frizzled receptor antibodies for treatment of cancer

Similar Documents

Publication Publication Date Title
JP7345578B2 (ja) 新規抗pd-l1抗体
US10604576B2 (en) Antibodies and immunocytokines
KR102022734B1 (ko) 신규 조절제 및 용법
AU2011295715B9 (en) Novel modulators and methods of use
FI3332006T3 (fi) Uusia anti-PD-L1-vasta-aineita
RU2592672C2 (ru) Новые модуляторы и способы их применения
RU2012118643A (ru) Антитела против сиглека-15 для лечения заболевания, связанного с потерей костной массы
JP2015506912A5 (cg-RX-API-DMAC7.html)
JOP20190248A1 (ar) بروتينات ربط مولد ضد trem2 واستخداماته
JP2013513380A5 (cg-RX-API-DMAC7.html)
CN106536556A (zh) 结合lgr5的人源化抗体
KR20140047127A (ko) 암의 검출 및 진단을 위한 항체 i-3859의 용도
JP2020503359A5 (cg-RX-API-DMAC7.html)
CN113811545A (zh) 对btn2具有特异性的抗体及其用途
JP7813235B2 (ja) NPM1c陽性がんの免疫療法のための組成物および方法
WO2012019061A2 (en) Novel effectors and methods of use
WO2016090365A4 (en) Pdk1 binding molecules and uses thereof
JP6881658B2 (ja) Pd−1/cd3二重特異性タンパク質による血液がん治療
US20230235074A1 (en) Anti-bst2 antibodies targeting bst2 long isoform
KR20190107967A (ko) 한국인 위암 연관 유전자 단클론 항체 및 이의 제조방법
EA201992512A1 (ru) Антигенсвязывающие белки, связывающие trem2, и пути их применения
NZ739488A (en) Novel anti-pd-1 antibodies